CSL News
Most Popular CSL Story
CSL pays Talecris $75M, scraps merger deal
Australian vaccine maker CSL and Talecris Biotherapeutics have called a halt to a proposed $3.1 billion merger after running straight into a posse of U.S. antitrust regulators. CSL said that the cost Read more...
Latest Headlines
- November 8, 2011
- November 22, 2010
- July 16, 2010
- September 11, 2009
- June 9, 2009
- June 8, 2009
- May 29, 2009
- May 26, 2009
- August 13, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
